Condition
Colchicine Adverse Reaction
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
P 3 (1)
P 4 (3)
Trial Status
Unknown2
Completed1
Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07287345Phase 4Recruiting
Colchicine's Effect on Inflammatory Markers
NCT04224545Phase 4CompletedPrimary
COlchicine in Cardiac Surgery
NCT05168137Phase 4Unknown
Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy
NCT05006001Unknown
Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients
NCT03015831Phase 3Terminated
Effect of Low Dose ColchiciNe on the InciDence of POAF
Showing all 5 trials